News Releases

September 27, 2023

New Data at WSAVA Congress 2023 Reinforce MSD Animal Health’s Leadership in Companion Animal Science and Innovation as well as Commitment to Veterinarians

Symposium highlights data on an innovative, aqueous suspension of fluralaner for subcutaneous injection that was recently approved in Australia Scientific sessions highlight the importance of the One Health commitment to people, animals, environment Featured studies provide insights for otitis externa treatment, parasite prevention and infectious disease prevention RAHWAY, NJ — Sept. 27, 2023 – MSD […]

September 20, 2023

New Data from MSD Animal Health Demonstrates Efficacy of Monoclonal Antibody Against Cryptosporidium parvum Infection in Cattle

Study published in Infection and Immunity Currently no vaccine and few treatments available for cryptosporidiosis, a significant diarrheal disease in both people and animals worldwide RAHWAY, N.J., September 20, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the publication of a new study that demonstrates […]

August 29, 2023

New Poultry Data from MSD Animal Health to be Highlighted at WVPAC 2023

INNOVAX®-ILT-IBD, the first vaccine to prevent ILT, IBD, and MD in a single dose, now available in the EU, will be highlighted in a symposium Multiple studies continue to support the benefit of INNOVAX®-ND-IBD, the first vaccine against classic and variant IBD, ND and MD in a single dose RAHWAY, N.J., August 29, 2023 – […]

August 24, 2023

MSD Animal Health Presents New Data on First Vaccine to Reduce C. Parvum Infection at the European Buiatrics Congress and ECBHM Jubilee Symposium 2023

Gp40 antigen vaccine elicits immune response against Cryptosporidium parvum in pregnant cows to protect their newborn calves through antibodies in colostrum Combined data represent first efficacious C. parvum maternal vaccine worldwide for any species RAHWAY, N.J., August 24, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced […]

August 22, 2023

MSD Animal Health Launches New FALCON® Biomass to Improve Fish Farming Operations

Biomass estimation unit provides key information about average weight, distribution, and growth trends RAHWAY, N.J., August 21, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the launch of FALCON® Biomass, a powerful, always-on biomass estimation unit that provides key information about average weight, distribution, and […]

June 12, 2023

MSD Animal Health Receives EU Approval of INNOVAX®-ILT-IBD

First EU-licensed poultry vaccine to prevent development of ILT, IBD and MD without the risk of reversion to virulence of ILT Rahway, N.J., June 12, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today that the European Commission has approved INNOVAX®-ILT-IBD, a dual-construct HVT vaccine that provides […]

May 24, 2023

MSD Animal Health Presents New Data Highlighting Commitment to the Health and Well-Being of Swine, As Well As Pig Farm Management at ESPHM 2023

Multiple studies demonstrate the benefit of needle-free vaccination for the prevention and management of Lawsonia intracellularis Additional novel research includes reproductive health, preventive farm care and herd health management MADISON, N.J., May 24, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the presentation of 19 […]

May 1, 2023

MSD Animal Health Announces Approval of BRAVECTO QUANTUM™ (fluralaner) in Australia, the First and Only Injectable Parasiticide to Provide Up to a Full Year of Flea and Tick Protection for Dogs

Novel injectable suspension delivers ongoing efficacy against fleas and ticks for dogs six months and older in a single dose MADISON, N.J., May 1, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the Australian Pesticides and Veterinary Medicines Authority (APVMA) has approved a novel injectable […]

April 4, 2023

MSD Animal Health Receives Marketing Authorization from European Commission for BOVILIS® Nasalgen®-C Live Vaccine for Cattle

First vaccine for bovine coronavirus (BCoV), to protect newborn calves against respiratory disease MADISON, NJ, APRIL 4, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the European Commission granted marketing authorization for BOVILIS® Nasalgen®-C, a bovine coronavirus (BCoV) vaccine for cattle. The intranasal, live vaccine can […]

March 16, 2023

MSD Animal Health to Host Global Continuing Education Symposium Focused on Companion Animal Vaccination

Virtual event featuring 12 global experts offered free to veterinary professionals MADISON, N.J., March 16, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the company will host a virtual continuing education symposium featuring 12 experts from around the world. This event, sponsored by NOBIVAC® will be […]